Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Depreciation and Depletion (2020 - 2025)

Pulmonx (LUNG) has disclosed Depreciation and Depletion for 6 consecutive years, with $300000.0 as the latest value for Q3 2025.

  • Quarterly Depreciation and Depletion changed 0.0% to $300000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Sep 2025, down 16.67% year-over-year, with the annual reading at $1.1 million for FY2024, 21.43% down from the prior year.
  • Depreciation and Depletion for Q3 2025 was $300000.0 at Pulmonx, roughly flat from $300000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $500000.0 in Q4 2022, with the low at $100000.0 in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $284210.5, with a median of $300000.0 recorded in 2021.
  • The sharpest move saw Depreciation and Depletion surged 200.0% in 2022, then plummeted 66.67% in 2024.
  • Over 5 years, Depreciation and Depletion stood at $300000.0 in 2021, then skyrocketed by 66.67% to $500000.0 in 2022, then plummeted by 40.0% to $300000.0 in 2023, then tumbled by 66.67% to $100000.0 in 2024, then soared by 200.0% to $300000.0 in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $300000.0, $300000.0, and $300000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.